Solunum Yetmezliği
Synopsis
Acute respiratory failure is a serious complication frequently seen in hospitalized patients, serving as the most common cause of intensive care unit admissions and carrying a high mortality rate of approximately 50% depending on underlying conditions. Defined as a PaO2 level below 60 mmHg or a PaCO2 level above 45 mmHg in room air, respiratory failure is classified into four main groups: hypoxemic (type 1), hypercapnic (type 2), perioperative, and shock-related respiratory failure. In pathophysiological processes, ventilation-perfusion mismatch, right-to-left shunt, alveolar hypoventilation, diffusion impairment, breathing with low FiO2, and desaturation of mixed venous blood constitute the primary mechanisms. Patients exhibit clinical signs such as dyspnea, tachypnea, bradypnea, cyanosis, tachycardia, use of accessory respiratory muscles, and altered consciousness. In the diagnostic approach, blood gas analysis and chest radiography are initially applied, while thoracic CT, echocardiography, V/Q scintigraphy, and viral RT-PCR tests are utilized for differential diagnosis. The cornerstone of treatment is supplemental oxygen therapy along with addressing the underlying cause. Accordingly, conventional oxygen therapy, heated humidified high-flow nasal cannula, non-invasive and invasive mechanical ventilation, antibacterial drugs, prone positioning, inhaled pulmonary vasodilators, corticosteroids, ECMO, and appropriate antiviral agents in pandemic situations are employed.
References
Lee CC, Mankodi D, Shaharyar S, et al. High flow nasal cannula versus conventional oxygen therapy and non-invasive ventilation in adults with acute hypoxemic respiratory failure: A systematic review. Respiratory Medicine. 2016; 121: 100-108. Doi: 10.1016/j.rmed.2016.11.004
Azoulay E, Mokart D, Kouatchet A. Acute respiratory failure in immunocompromised adults. Lancet Respir Med. 2019; 7: 173–86. Doi: 10.1016/S2213-2600(18)30345-X
Kaya A. & Çiledağ A. (2016). Solunum yetmezliği. Başar Cander (Ed.), Acil Tıp Temel Başvuru Kitabı içinde (s. 557-564). İstanbul: İstanbul tıp kitapevleri
Ellinghaus D, Degenhardt F, Bujanda L, et al. Genomewide Association Study of Severe Covid-19 with Respiratory Failure. N Engl J Med.2020; 383(16):1522-1534. Doi: 10.1056/NEJMoa2020283
Alhassan S, Sayf AA, Arsene C, et al. Suboptimal implementation of diagnostic algorithms and over use of computed tomography pulmonary anjiography in patients with suspected pulmonary embolism. Annals of Toracic Medicine. 2016;11: 254-60. Doi: 10.4103/1817-1737.191875
Zhou M, Zhang X, Qu J. Coronavirus disease 2019 (COVID-19): A clinical update. Front Med 2020;14(2):126-135. Doi: 10.1007/s11684-020-0767-8
Pascarella G, Strumia1A, Piliego C, et al. Covıd-19 diagnosis and management: a comprehensive review. J Intern Med. 2020;288(2):192-206. Doi: 10.1111/joim.13091
Fang B, Meng QH. The laboratory’s role in combating Covıd-19. Crit Rev Clin Lab Sci. 2020;57(6):400-414. Doi: 10.1080/10408363.2020.1776675
Wan DY, Luo XY, Dong W et al. Current practice and potential strategy in diagnosing Covıd-19. Eur Rev Med Pharmacol Sci 2020;24(8):4548-4553. Doi: 10.26355/eurrev_202004_21039.
Frater JL, Zini G, d'Onofrio G et al. Covıd-19 and the clinical hematology laboratory. Int J Lab Hematol 2020;42:11-18. Doi: 10.1111/ijlh.13229
Pontia G, Maccaferrib M, Ruini C et al. Biomarkers associated with Covıd-19 disease progression. Crit Rev Clin Lab Sci. 2020;57(6):389-399. Doi: 10.1080/10408363.2020.1770685.
Pambuccian SE The Covıd-19 pandemic: implications for the cytology laboratory. J Am Soc Cytopathol.2020;9(3):202-211. Doi: 10.1016/j.jasc.2020.03.001
Sorayaa GV, Ulhaqb ZS et al. Crucial laboratory parameters in Covıd-19 diagnosis and prognosis:An updated meta-analysis. Med Clin (Barc) 2020;155(4):143-151. Doi: 10.1016/j.medcli.2020.05.017
Fielding-Singh V, Michael A. Matthay MA, Carolyn S. Calfee. Beyond Low Tidal Volume Ventilation Treatment Adjuncts for Severe Respiratory Failure in Acute Respiratory Distress Syndrome. Crit Care Med. 2018 ; 46(11): 1820–1831. Doi:10.1097/CCM.0000000000003406.
https://covid19.saglik.gov.tr/Eklenti/39061/0/covid-19rehberieriskinhastatedavisipdf.pdf